Lakeshore Biopharma Co, Stock Fundamentals
| LSBPW Stock | 0.06 0.00 0.00% |
LakeShore Biopharma Co, fundamentals help investors to digest information that contributes to LakeShore Biopharma's financial success or failures. It also enables traders to predict the movement of LakeShore Stock. The fundamental analysis module provides a way to measure LakeShore Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LakeShore Biopharma stock.
Total Operating Expenses is likely to climb to about 1.1 B in 2025, despite the fact that Tax Provision is likely to grow to (18.6 M). LakeShore | Select Account or Indicator |
LakeShore Biopharma Co, Company Return On Asset Analysis
LakeShore Biopharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current LakeShore Biopharma Return On Asset | -0.14 |
Most of LakeShore Biopharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LakeShore Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionLakeShore Total Assets
Total Assets |
|
Based on the latest financial disclosure, LakeShore Biopharma Co, has a Return On Asset of -0.1385. This is 98.42% lower than that of the Healthcare sector and 99.41% lower than that of the Biotechnology industry. The return on asset for all United States stocks is 1.07% lower than that of the firm.
LakeShore Biopharma Co, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LakeShore Biopharma's current stock value. Our valuation model uses many indicators to compare LakeShore Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LakeShore Biopharma competition to find correlations between indicators driving LakeShore Biopharma's intrinsic value. More Info.LakeShore Biopharma Co, is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, LakeShore Biopharma's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value LakeShore Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.LakeShore Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in return on asset category among its peers.
LakeShore Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.76) % | ||||
| Operating Margin | (0.69) % | ||||
| Number Of Shares Shorted | 23.24 K | ||||
| Revenue | 573.42 M | ||||
| Gross Profit | 386.06 M | ||||
| EBITDA | (368.66 M) | ||||
| Net Income | (433.46 M) | ||||
| Total Debt | 424.46 M | ||||
| Book Value Per Share | 30.76 X | ||||
| Cash Flow From Operations | (295.23 M) | ||||
| Number Of Employees | 758 | ||||
| Beta | 0.68 | ||||
| Total Asset | 1.51 B | ||||
| Retained Earnings | (2.31 B) | ||||
| Working Capital | 100.94 M | ||||
| Net Asset | 1.51 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.8 M | 1.7 M | |
| Total Revenue | 659.4 M | 555.7 M | |
| Cost Of Revenue | 135.3 M | 123.1 M | |
| Stock Based Compensation To Revenue | 0.02 | 0.02 | |
| Sales General And Administrative To Revenue | 0.30 | 0.31 | |
| Research And Ddevelopement To Revenue | 0.48 | 0.35 | |
| Capex To Revenue | 0.09 | 0.08 | |
| Revenue Per Share | 6.17 | 11.07 | |
| Ebit Per Revenue | (0.89) | (0.85) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.